Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enveric Biosciences Inc (NQ: ENVB ) 0.4710 +0.0010 (+0.21%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enveric Biosciences Inc < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > 15 Global Psychedelics Executives To Keep An Eye On In 2022 October 28, 2022 As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list... Via Benzinga Enveric Biosciences Advances Lead Candidate for the Treatment of Anxiety Disorders to IND-Enabling Studies October 24, 2022 From Enveric Biosciences Inc. Via Business Wire Enveric Biosciences Announces Poster Presentations of Lead Programs at the 2022 International Neurology & Brain Disorders Conference October 12, 2022 From Enveric Biosciences Via Business Wire 12 Health Care Stocks Moving In Thursday's After-Market Session September 29, 2022 Gainers Via Benzinga Psychedelics May Make People Less Afraid of Death September 07, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death change... Via FinancialNewsMedia Topics Supply Chain Exposures Supply Chain Enveric Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 August 31, 2022 From Enveric Biosciences, Inc. Via Business Wire World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them August 30, 2022 The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... Via Benzinga 7 Psychedelics Stocks to Buy for a Big Drug Boom August 30, 2022 These are the seven psychedelics stocks to buy in September. PSIL, ATAI, CMPS, CYBN, ENVB, GHRS and MNMD can make great investments Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session August 18, 2022 Via Benzinga 7 Short-Squeeze Stocks to Put on Your Must-Watch List August 16, 2022 If you want to zig while the bears zag, these short-squeeze stocks to put on your radar may make for handsome profits. Via InvestorPlace Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression August 10, 2022 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study... Via FinancialNewsMedia Topics Supply Chain Exposures Supply Chain Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday August 08, 2022 Pre-market stock movers are the hot topic this morning as we cover all the latest news sending shares higher and lower on Monday! Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday August 04, 2022 Good morning! It's time for another dive into the biggest pre-market stock movers as we see what's affecting shares on Thursday! Via InvestorPlace Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday August 05, 2022 Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share... Via Benzinga Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session August 04, 2022 Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. Via Benzinga Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket August 04, 2022 Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session August 03, 2022 Gainers Via Benzinga Enveric Biosciences Appoints New Independent Directors July 27, 2022 From Enveric Biosciences, Inc. Via Business Wire This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday August 04, 2022 Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. Via Benzinga Enveric Biosciences Announces Closing of $8 Million Registered Direct and Private Placement Offerings, Priced at a Premium to Market Under Nasdaq Rules July 26, 2022 From Enveric Biosciences, Inc. Via Business Wire Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday July 26, 2022 Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday. Via Benzinga Nasdaq Drops 100 Points; Crude Oil Rises Sharply July 25, 2022 U.S. stocks traded mostly lower toward the end of trading on Monday. Via Benzinga Dow Rises Over 100 Points; Revelation Biosciences Shares Spike Higher July 25, 2022 U.S. stocks traded mostly higher midway through trading on Monday. Via Benzinga Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session July 25, 2022 Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis. Via Benzinga Why U.S. Stocks Are Trading Mostly Higher; Chicago Fed National Activity Index Remains Unchanged July 25, 2022 U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 100 points on Monday. Via Benzinga Enveric Biosciences Stock Is Nosediving Today: What's Happening? July 25, 2022 Enveric Biosciences Inc (NASDAQ: ENVB) shares are trading lower by 21.84% to $7.55 Monday morning after the company announced an $8 million registered direct offering and private placement. Via Benzinga Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact July 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 11 Health Care Stocks Moving In Monday's Pre-Market Session July 25, 2022 Via Benzinga Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules July 25, 2022 From Enveric Biosciences, Inc. Via Business Wire This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday July 25, 2022 Gainers Via Benzinga < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.